Who invested in Kinoxis Therapeutics?
Kinoxis Therapeutics's investors include iSeed, Uniseed Ventures, Main Sequence Ventures and National Institutes of Health. Main Sequence Ventures led its latest round.

Australia · Series B startup
Funding summaryUpdated 26 Oct 2026
$14Mraised across 2 rounds since 2024, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From Kinoxis Therapeutics's own website: 2 founders, 9 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Kinoxis Therapeutics's investors include iSeed, Uniseed Ventures, Main Sequence Ventures and National Institutes of Health. Main Sequence Ventures led its latest round.
Kinoxis Therapeutics has raised $14M across 2 rounds since 2024.
Kinoxis Therapeutics's most recent round, $4.8M, was in Sept 2026, led by Main Sequence Ventures.
Kinoxis Therapeutics's largest round on record is $9.5M (Series B), in Aug 2024.
Kinoxis Therapeutics's first round on record, in Aug 2024, was backed by National Institutes of Health, iSeed and Uniseed Ventures.
Kinoxis Therapeutics's latest named round is a Series B, in Aug 2024.
Kinoxis Therapeutics is based in Australia.
Main Sequence Ventures led the funding round in 2026.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.